Clinical course and prediction of survival in idiopathic pulmonary fibrosis (Q37799183)

23 August 2017

title

Clinical course and prediction of survival in idiopathic pulmonary fibrosis (English)

1 reference

23 August 2017

1 reference

Brett Ley

1

1 reference

23 August 2017

Harold R Collard

series ordinal

2

1 reference

23 August 2017

Talmadge E King

series ordinal

3

1 reference

23 August 2017

language of work or name

English

0 references

publication date

8 October 2010

1 reference

American Journal of Respiratory and Critical Care Medicine

23 August 2017

published in

1 reference

23 August 2017

volume

183

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

431-440

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

23 August 2017

1 reference

Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

The clinical course of patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Idiopathic pulmonary fibrosis: challenges and opportunities for the clinician and investigator

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Clinical and pathologic features of familial interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Early interstitial lung disease in familial pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Identification of early interstitial lung disease in smokers from the COPDGene Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Subclinical idiopathic pulmonary fibrosis is also a risk factor of postoperative acute respiratory distress syndrome following thoracic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Clinically occult subpleural fibrosis and acute interstitial pneumonia a precursor to idiopathic pulmonary fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Pirfenidone in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Acute exacerbations of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Acute exacerbation of idiopathic pulmonary fibrosis: role of Chlamydophila pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Acute exacerbation of chronic interstitial pneumonia: high-resolution computed tomography and pathologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Seasonal variation: mortality from pulmonary fibrosis is greatest in the winter

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Clinical significance of histological classification of idiopathic interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Incidence and prevalence of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Determinants of survival in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Racial and ethnic disparities in survival in lung transplant candidates with idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Racial and ethnic disparities in idiopathic pulmonary fibrosis: A UNOS/OPTN database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

The 'healthy smoker': a phenomenon of health selection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Heterogeneity in combined pulmonary fibrosis and emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Idiopathic pulmonary fibrosis and emphysema in smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Vertical gradients of lung density in supine subjects with fibrosing alveolitis or pulmonary emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Cryptogenic fibrosing alveolitis with preserved lung volumes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Idiopathic pulmonary fibrosis: how often is it really idiopathic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Does chronic microaspiration cause idiopathic pulmonary fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Association of malignancy with diseases causing interstitial pulmonary changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Prognostic determinants among clinical, thin-section CT, and histopathologic findings for fibrotic idiopathic interstitial pneumonias: tertiary hospital study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Radiological versus histological diagnosis in UIP and NSIP: survival implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Changes in Pulmonary Function Test Results After 1 Year of Therapy as Predictors of Survival in Patients With Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Quantitative analysis of fibroblastic foci in usual interstitial pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Organizing pneumonia and lymphoplasmacytic inflammation predict treatment response in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Serum albumin concentration and waiting list mortality in idiopathic interstitial pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Surfactant protein A predicts survival in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Validation, updating and impact of clinical prediction rules: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Clinical prediction rules. A review and suggested modifications of methodological standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Body Mass Index and Mortality in Patients With Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

Pulmonary Hypertension in Patients With Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0894CI

10.1164/RCCM.201006-0894CI

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference